Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)

Exclusion Criteria

• •Active viral infection based on clinical observations
• •Cardiac magnetic resonance imaging (MRI) determined left ventricular ejection fraction (LVEF) \<40%
• •Serological evidence of human immunodeficiency virus (HIV), hepatitis B, or hepatitis C infection
• •Diagnosis of (or ongoing treatment for) an autoimmune disease
• •Abnormal laboratory values considered clinically significant
• •Concomitant illness or requirement for chronic drug treatment that, in the opinion of the Principal Investigator, creates unnecessary risks for gene transfer.